Summary
This webinar will help Weil members identify grant opportunities for studies on ARDS, pneumonia, and sepsis.
Weil Institute leaders and members were recently awarded an NIH grant to lead a clinical center for the ARDS, Pneumonia and Sepsis (APS) Phenotyping Consortium, involving a prospective, longitudinal observational study with common data and biospecimen collection of 5,000 adults hospitalized with APS across the nation.
In this webinar, Dr. Robert Dickson and Dr. Kathleen Stringer will share the finalized APS protocol, allowing Weil members to plan future NIH grant submissions leveraging the APS data and biospecimens that will be collected. Drs. Dickson and Stringer will also discuss how NIGMS and NHLBI will support new grants that leverage the APS Consortium, as well as other NIH biorepositories that investigators can leverage for secondary studies, such as NHLBI’s BioLINCC.
NOTE: This event is open to Weil members only.
Speakers
Robert Dickson, MD
Deputy Director, Weil Institute; Associate Professor, Pulmonary and Critical Care Medicine, Microbiology and Immunology
Kathleen Stringer, PharmD
Deputy Director, Weil Institute; Albert B. Prescott Professor, Clinical Pharmacy